U.S. fund to invest $20M in Korean firm’s anti-coronavirus technology
South Korean startup Haim Bio announced that a U.S. fund operated by A&P Partners had agreed to invest $20 million in its anti-coronavirus technology. #DmtDaily
News
via https://www.DMT.NEWS
, Khareem Sudlow
News
via https://www.DMT.NEWS
, Khareem Sudlow